- Home
- GRCE vs AMPG Comparison
GRCE vs AMPG Comparison
Compare GRCE & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- AMPG
- Stock Information
- Founded
- GRCE 2002
- AMPG 2002
- Country
- GRCE United States
- AMPG United States
- Employees
- GRCE N/A
- AMPG N/A
- Industry
- GRCE
- AMPG Telecommunications Equipment
- Sector
- GRCE
- AMPG Telecommunications
- Exchange
- GRCE NYSE
- AMPG Nasdaq
- Market Cap
- GRCE 42.4M
- AMPG 46.7M
- IPO Year
- GRCE N/A
- AMPG N/A
- Fundamental
- Price
- GRCE $3.08
- AMPG $3.07
- Analyst Decision
- GRCE Strong Buy
- AMPG Strong Buy
- Analyst Count
- GRCE 1
- AMPG 1
- Target Price
- GRCE $12.00
- AMPG $5.00
- AVG Volume (30 Days)
- GRCE 62.2K
- AMPG 483.5K
- Earning Date
- GRCE 08-15-2025
- AMPG 08-13-2025
- Dividend Yield
- GRCE N/A
- AMPG N/A
- EPS Growth
- GRCE N/A
- AMPG N/A
- EPS
- GRCE N/A
- AMPG N/A
- Revenue
- GRCE N/A
- AMPG $10,814,140.00
- Revenue This Year
- GRCE N/A
- AMPG $114.55
- Revenue Next Year
- GRCE N/A
- AMPG $50.00
- P/E Ratio
- GRCE N/A
- AMPG N/A
- Revenue Growth
- GRCE N/A
- AMPG N/A
- 52 Week Low
- GRCE $1.75
- AMPG $0.64
- 52 Week High
- GRCE $4.97
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- AMPG 68.00
- Support Level
- GRCE N/A
- AMPG $2.61
- Resistance Level
- GRCE N/A
- AMPG $3.20
- Average True Range (ATR)
- GRCE 0.00
- AMPG 0.22
- MACD
- GRCE 0.00
- AMPG 0.07
- Stochastic Oscillator
- GRCE 0.00
- AMPG 88.50
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.